pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
ECC-0509
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0 catalysts
Phase 2
ECC-4703
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Eccogene (Shanghai) Co Ltd
0 catalysts
Phase 3
ECUR-506
Ornithine-Transcarbamylase Deficiency
iECURE Inc
0 catalysts
Phase 2
EDV-2209
Subarachnoid Hemorrhage
← prev
page 80 of 231
next →
131
Pain89
Neurology1
Edvince AB
0 catalysts
Phase 2
EEDVD-682
Pancreatic Ductal Adenocarcinoma
EnGeneIC Ltd
0 catalysts
Phase 2
EF-001
Anaplastic Astrocytoma
Everfront Biotech Inc
0 catalysts
Preclinical
EF-005
Alzheimer's Disease
Everfront Biotech Inc
0 catalysts
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)
CIPLA
0 catalysts
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE (EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)
LAURUS
0 catalysts
Phase 1
EG-001
Idiopathic Interstitial Pneumonia (IIP)
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 2
EG-007
Endometrial Cancer
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 1
EG-009
Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Preclinical
EG-102
Focal Segmental Glomerulosclerosis (FSGS)
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 2
EG-110A
Neurogenic Bladder Dysfunction
EG 427
0 catalysts
Preclinical
EG-201
Wet (Neovascular / Exudative) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Preclinical
EG-401
Diabetic Retinopathy
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Preclinical
EG-402
Retinopathy Of Prematurity
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 2
EG-501
Cognitive Impairment
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Preclinical
EG-Mirotin
Diabetic Retinopathy
EyeGene Inc
0 catalysts
Phase 2
EGT-101
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0 catalysts
Preclinical
EGT-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Esteve Pharmaceuticals SA
0 catalysts
Preclinical
EGT-301
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Esteve Pharmaceuticals SA
0 catalysts
Phase 2
EH-301
Amyotrophic Lateral Sclerosis
Elysium Health Inc
0 catalysts
Preclinical
EIR-0205
Dry (Atrophic) Macular Degeneration
EIR Biopharma Inc
0 catalysts
Preclinical
EIR-1003
Neovascular Glaucoma
EIR Biopharma Inc
0 catalysts
Phase 2
EIS-12656
Breast Cancer
Eisbach Bio GmbH
0 catalysts
Preclinical
EKZ-102
Parkinson's Disease
Eikonizo Therapeutics Inc
0 catalysts
Preclinical
EL-100
Critical Limb Ischemia
Elphis Cell Therapeutics Co Ltd
0 catalysts
Phase 1
EL-22
Obesity
Northstrive Biosciences Inc
0 catalysts